Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat
Open Access
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (2) , 896-902
- https://doi.org/10.1111/j.1476-5381.1993.tb13897.x
Abstract
1 The role of arachidonic acid metabolites and oxygen radicals in carrageenin-induced rat paw oedema and dermal reverse passive Arthus reaction (RPA) have been investigated. 2 Indomethacin (10 mg kg−1, p.o.) inhibited carrageenin paw oedema when administered 30 min before, but not 2 h after carrageenin. BWB70C (10 mg kg−1, p.o.), a selective inhibitor of 5-lipoxygenase, had no effect whether administered before or after carrageenin. Administration of both indomethacin and BWB70C had no greater anti-inflammatory effect than indomethacin alone. 3 BW755C (20 mg kg−1, p.o.), which inhibits the cyclo-oxygenase and lipoxygenase pathways of arachidonic acid metabolism, or superoxide dismutase-polyethylene glycol conjugate (SOD-PEG, 3000 u, i.v.) inhibited carrageenin paw oedema whether administered either 30 min before, or 2 h after carrageenin. 4 Pretreatment with dexamethasone (0.1 mg kg−1) or colchicine (2 mg kg−1), likewise suppressed carrageenin paw oedema. 5 BW755C (25–100 mg kg−1, p.o.) dose-dependently reduced plasma leakage in the RPA, whereas indomethacin (5 mg kg−1, p.o.) or BWB70C either alone or in combination, did not. 6 SOD-PEG (300–3000 u, i.v.) dose-dependently inhibited plasma leakage in the RPA. In addition, the iron chelator and peroxyl radical scavenger, desferrioxamine (200 mg kg−1, s.c.) also inhibited plasma leakage. 7 Pretreatment with dexamethasone (0.1 mg kg−1) or colchicine (1 mg kg−1) reduced the plasma leakage in RPA, whereas MK-886 (10 mg kg−1) had no effect. 8 These results indicate an important role for oxygen radicals but not arachidonic acid metabolites in the maintenance of carrageenin paw oedema and the plasma leakage in RPA. Furthermore, the results suggest that the anti-inflammatory actions of BW755C can be dissociated from its effects on arachidonic acid metabolism and are attributed to its anti-oxidant activity.Keywords
This publication has 38 references indexed in Scilit:
- Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the ratBiochemical and Biophysical Research Communications, 1990
- Role of O2− in neutrophil recruitment into sites of dermal and pulmonary vasculitisFree Radical Biology & Medicine, 1990
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- Pharmacological profiles of a potential LTB4-antagonist, SM-9064Biochemical and Biophysical Research Communications, 1986
- In vivo and in vitro assessment of the role of leukotriene B4 as a mediator of rat cutaneous late-phase reactionsJournal of Allergy and Clinical Immunology, 1986
- Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reactionInflammation Research, 1982
- Measurement of Cutaneous Inflammation: Estimation of Neutrophil Content with an Enzyme MarkerJournal of Investigative Dermatology, 1982
- Inhibition of arachidonic acid cyclo-oxygenase and lipoxygenase activities of leukocytes by indomethacin and compound BW755CInflammation Research, 1980
- The arthus reaction in rats, a possible test for anti-inflammatory and antirheumatic drugsInflammation Research, 1979
- Role of prostaglandin-mediated vasodilatation in inflammationNature, 1977